Open access
Aug 2026
Heart Failure With Reduced Ejection Fraction and SGLT2 Inhibitors- Clinical Outcomes, Adverse Events, and Comorbidities Over Three Years: A Retrospective Cohort Study
SGLT2 inhibitor use in heart failure with reduced ejection fraction was associated with significantly improved long-term survival and a substantial reduction in heart failure and acute coronary syndrome hospitalizations, without increased risk of AKI or UTI.
Jonathan Zawadzki, Ronit Kar, G. Bailey et al.
· Journal of Clinical Cardiolo... · 0 citations